EMCC European Monitoring Centre on Change



Geographic Location

Country: Ireland
Region: Border; Border, Midland and Western


Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Number Employed: 2200
Group: Abbott Group (US)

Employment Effects

Announcement Date: 22-03-2006
Type of Restructuring: Business expansion
Employment Effect Start: 01-01-2007
Planned Job Creation: 155

Additional Information

Abbott Laboratories yesterday announced plans for a €36 million investment in Donegal, creating 155 jobs. The US group, which already operates six plants in the Republic of Ireland, said it would acquire the Donegal town plant of Hospira Ireland, originally part of the Abbott group. Abbott's diabetes care division will manufacture test strips for use in the company's blood glucose monitoring systems. The US-owned Abbott group spun off its hospital products division into a separate publicly-listed company, Hospira, in April 2004. In August 2005 last, Hospira announced it was closing its medical goods factory in Donegal, with the 560 jobs there being phased out by the end of 2006. Many of the new jobs are likely to be filled by laid-off by Hospira workers. Abbott said it expected to begin production in Donegal in 2007. Recruitment will start in the second half of this year with the 155-job target being achieved over several years. Abbott employs more than 2,200 people in Ireland, making it one of the country's most significant multinational employers and making the Republic one of its largest overseas locations.